How do we solve a problem like medicines adherence?
Despite decades of research, rates of adherence to medicines remain stubbornly low. New ways of thinking and innovative use of technology may help us turn a corner.…
News
See all-
How The Pharmaceutical Journal supports foundation trainees in revising and preparing for the GPhC registration exam
-
NICE recommends cladribine for treating active relapsing forms of multiple sclerosis
-
The pharmacy funding boost is a step in the right direction but it will not go far enough
-
Earlier treatment with combination of drugs could prevent 5,000 heart attacks per decade, study results suggest
-
Regulators issue warning over prescription-only weight-loss drug advertisements
Learning & CPD
How The Pharmaceutical Journal supports foundation trainees in revising and preparing for the GPhC registration exam
NICE recommends cladribine for treating active relapsing forms of multiple sclerosis
The pharmacy funding boost is a step in the right direction but it will not go far enough
Earlier treatment with combination of drugs could prevent 5,000 heart attacks per decade, study results suggest
Regulators issue warning over prescription-only weight-loss drug advertisements
Yvonne Burton (1963–2025)
How do we solve a problem like medicines adherence?
Haemato-oncology
Chronic lymphocytic leukaemia: diagnosis and management
Supported content
BRUKINSA is now reimbursed across the UK for R/R MZL
Promotional content
How can pharmacists best support patients with chronic lymphocytic leukaemia?
Supported content
Management of Waldenstrom’s macroglobulinaemia
Supported content
BTK inhibitors: what pharmacists need to know
Supported content
BRUKINSA: a next-generation BTK inhibitor
Promotional content
Genomics
How The Pharmaceutical Journal supports foundation trainees in revising and preparing for the GPhC registration exam
NICE recommends cladribine for treating active relapsing forms of multiple sclerosis
The pharmacy funding boost is a step in the right direction but it will not go far enough
Earlier treatment with combination of drugs could prevent 5,000 heart attacks per decade, study results suggest
Regulators issue warning over prescription-only weight-loss drug advertisements
Yvonne Burton (1963–2025)
How do we solve a problem like medicines adherence?
Tributes & obituaries
View all-
How The Pharmaceutical Journal supports foundation trainees in revising and preparing for the GPhC registration exam
-
NICE recommends cladribine for treating active relapsing forms of multiple sclerosis
-
The pharmacy funding boost is a step in the right direction but it will not go far enough
-
Earlier treatment with combination of drugs could prevent 5,000 heart attacks per decade, study results suggest
-
Regulators issue warning over prescription-only weight-loss drug advertisements
-
Yvonne Burton (1963–2025)
-
How do we solve a problem like medicines adherence?
-
Community pharmacy RSV expansion programme to be expanded four-fold
Want to see content related to your country or pharmacy sector on your homepage? Visit your preference centre to update your interests and help us improve your digital experience.
Newly registered?
Find our dedicated career advice and resources, clinical CPD and professional skills content here.
Research
See all-
How The Pharmaceutical Journal supports foundation trainees in revising and preparing for the GPhC registration exam
-
NICE recommends cladribine for treating active relapsing forms of multiple sclerosis
- Advertisement
-
The pharmacy funding boost is a step in the right direction but it will not go far enough
-
Earlier treatment with combination of drugs could prevent 5,000 heart attacks per decade, study results suggest
-
Regulators issue warning over prescription-only weight-loss drug advertisements
-
Yvonne Burton (1963–2025)